11976826001
Roche
MIA ELISA
sufficient for ≤96 tests, Roche, kit of 1 (9 components), suitable for ELISA
Sinonimo/i:
ELISA
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Codice UNSPSC:
41116158
Prodotti consigliati
impiego
sufficient for ≤96 tests
Livello qualitativo
Confezionamento
kit of 1 (9 components)
Produttore/marchio commerciale
Roche
tecniche
ELISA: suitable
Temperatura di conservazione
2-8°C
Descrizione generale
One-step immunoreaction—photometric enzyme immunoassay for the quantitative in vitro determination of human Melanoma Inhibitory Activity (MIA) in streptavidin-coated microplates.
Standards: Six standards, ranging from 0 to 50 ng/ml MIA protein, are provided with lot-specific data.
Standards: Six standards, ranging from 0 to 50 ng/ml MIA protein, are provided with lot-specific data.
Specificità
The MIA ELISA detects natural and recombinant human melanoma inhibitory activity protein. No cross-reaction with other serum components has been found.
Immunogeno
Detailed epitope structure is not known. The epitopes recognized by the antibodies are conformation epitopes, no linear structures. This is why the abs are not suitable for Western (denaturation destroys epitopes). The two antibodies recognize different epitopes (non-overlapping).
The antibodies recognize non-overlapping epitopes, which are conformational epitopes (no linear sequence is recognized but rather parts of 3D-conformation). Exact epitopes have not been determined.
The antibodies recognize non-overlapping epitopes, which are conformational epitopes (no linear sequence is recognized but rather parts of 3D-conformation). Exact epitopes have not been determined.
Applicazioni
For research use only. Not for use in diagnostic procedures.
The MIA ELISA is an ideal application in research studies determining the melanoma inhibitory activity protein in serum and plasma.
The MIA ELISA is specially developed for the quantitative in vitro determination of MIA protein in serum and plasma within streptavidin-coated microplates (MPs). It has a wide applictaion in MIA (melanoma inhibitory activity) ELISA assays.[1]
The MIA ELISA is an ideal application in research studies determining the melanoma inhibitory activity protein in serum and plasma.
The MIA ELISA is specially developed for the quantitative in vitro determination of MIA protein in serum and plasma within streptavidin-coated microplates (MPs). It has a wide applictaion in MIA (melanoma inhibitory activity) ELISA assays.[1]
Confezionamento
1 kit containing 9 components.
Nota sulla preparazione
Working solution: Beside the ready-to-use solutions supplied with this kit, you will need to prepare the following working solution:
Roche recommends using only double distilled water for the reconstitution of lyophylizates.
Storage conditions (working solution): Anti-MIA-Biotin (vial 1):
6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
Anti-MIA-Peroxidase (vial 2):
6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
MIA-Standard (vial 3):
1 day at 2 to 8 °C or 6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
MIA-Control Serum (vial 4):
1 day at 2 to 8 °C or 6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
Washing Buffer (vial 6): 1month at 2 to 8 °C
Immunoreagent: 8 hours at 2 to 8 °C
- Anti-MIA-Biotin: Reconstitute the lyophilizate in 0.7 ml double-dist. water for 10 minutes at 15 to 25 °C and mix thoroughly. Do not vortex.
Result: A clear, colorless solution. - Anti-MIA-Peroxidase: Reconstitute the lyophilizate in 0.7 ml double-dist. water for 10 minutes at 15 to 25 °C, and mix thoroughly. Do not vortex.
Result: A clear, slightly yellowish solution. - MIA Standard: Reconstitute the lyophilizate in 0.5 ml double-dist. water for 10 minutes at
15 to 25 °C, and mix thoroughly.Do not vortex.
Result: A clear, colorless solution. Concentration indicated on the label. - MIA Control Serum: Reconstitute the lyophilizate in 0.3 ml double-dist. water for 10 minutes at 15 to 25 °C, and mix thoroughly. Do not vortex.
Result: A Slightly opalescent and yellowish solution. Concentration indicated on the label. - Washing Buffer : Dissolve one tablet in 2 l of double-dist. water.
Result: A clear, colorless solution. - Immunoreagent: For 8 wells (1.8 ml): Add 50 μl reconstituted anti-MIA-Peroxidase (solution 2) to 1.7 ml Incubation Buffer, and mix well. Then add 50 μl of anti-MIA-biotin
(solution 1), and mix thoroughly. Do not vortex.
Result: A clear, colorless solution.
Roche recommends using only double distilled water for the reconstitution of lyophylizates.
Storage conditions (working solution): Anti-MIA-Biotin (vial 1):
6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
Anti-MIA-Peroxidase (vial 2):
6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
MIA-Standard (vial 3):
1 day at 2 to 8 °C or 6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
MIA-Control Serum (vial 4):
1 day at 2 to 8 °C or 6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
Washing Buffer (vial 6): 1month at 2 to 8 °C
Immunoreagent: 8 hours at 2 to 8 °C
Solo come componenti del kit
N° Catalogo
Descrizione
- Anti-MIA-biotin antibody, monoclonal from mouse, lyophilized (clone 2.F7.3B1)
- Anti-MIA-peroxidase antibody, monoclonal from mouse, lyophilized (clone 1.A12.9A1)
- MIA Standard, lyophilized
- MIA Control Serum, MIA in human serum, lyophilized approximately 25 ng/ml
- Incubation Buffer ready-to-use
- Washing Buffer
- ABTS Substrate Solution ready-to-use
- Streptavidin-coated Microplate modules
- Self-adhesive Plate Cover Foils
Vedi tutto (9)
Avvertenze
Warning
Indicazioni di pericolo
Consigli di prudenza
Classi di pericolo
Aquatic Chronic 3 - Skin Sens. 1
Codice della classe di stoccaggio
12 - Non Combustible Liquids
Classe di pericolosità dell'acqua (WGK)
WGK 3
Punto d’infiammabilità (°F)
does not flash
Punto d’infiammabilità (°C)
does not flash
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Harriet M Kluger et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 17(8), 2417-2425 (2011-04-14)
With the rising incidence of melanoma, more patients are undergoing surveillance for disease recurrence. Our purpose was to study levels of proteins that might be secreted in the blood of patients with metastatic melanoma that can be used for monitoring
Miyako Kurihara-Shimomura et al.
International journal of oncology, 56(5), 1093-1100 (2020-04-23)
Mast cells (MCs) are present in the tumor stroma, and MCs that express the mast cell‑specific proteases tryptase and chymase (MCTC) exhibit several tumor‑related functions. It was previously reported that melanoma inhibitory activity (MIA) gene family members, including MIA, MIA2
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.
